Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Movado Group, Inc. due to allegations of materially misleading business information issued by the company [1] Group 1: Allegations and Company Response - On April 11, 2025, Movado disclosed allegations of misconduct within its Dubai branch, related to sales practices in the Middle East, India, and Asia Pacific [3] - The company identified actions taken by the former managing director and certain employees that resulted in an overstatement of sales, premature recognition of sales, and underreporting of credit notes owed to customers [3] - Movado's financial statements dating back to 2022 will require restatements to accurately reflect sales and credits, indicating ineffective internal controls over financial reporting [3] Group 2: Stock Market Reaction - Following the news of the allegations, Movado's stock price fell to $13.56 per share, marking a 1.81% decrease from the previous closing price of $13.81 [3] Group 3: Legal Action and Investor Rights - Investors who purchased Movado Group securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses and encourages affected investors to join the action [2]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Backblaze, Inc. due to allegations of materially misleading business information issued by the company [1] Group 1: Investigation and Allegations - The investigation is prompted by a report from Morpheus Research that accused Backblaze of financial missteps and questionable accounting practices since its IPO in November 2021 [3] - The Morpheus Research report led to a significant drop in Backblaze's stock price, which fell by 2.1% on April 24, 2025 [3] Group 2: Class Action Details - Shareholders who purchased Backblaze securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2] - Interested investors can join the class action by submitting a form or contacting the Rosen Law Firm directly [2] Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and consistently ranking among the top firms for securities class action settlements since 2013 [4] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Light & Wonder, Inc. due to allegations of materially misleading business information [1] Group 1: Legal Actions and Implications - Shareholders who purchased Light & Wonder securities may be entitled to compensation through a class action without any out-of-pocket fees [2] - A preliminary injunction was granted to Aristocrat Technologies against Light & Wonder, prohibiting the sale or commercialization of the "Dragon Train" product, which allegedly infringes on Aristocrat's intellectual property [3] - Following the news of the injunction, Light & Wonder's stock experienced a significant decline of 19.49% on September 24, 2024 [3] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [4] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of HealthEquity, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Action and Investor Rights - Shareholders who purchased HealthEquity securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to HealthEquity [2]. Group 2: Company Performance and Market Reaction - HealthEquity's stock price fell by 17% on March 19, 2025, following an article that reported the company's missed profit estimates and weak guidance due to increased criminal activity targeting the firm [3].

SO WHAT: If you purchased AppLovin securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the AppLovin class action, go to https://rosenlegal.com/submit-form/? case_id=35884 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, yo ...

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of investors who sold or held shares of Cerevel Therapeutics Holdings, Inc. during a specified period, alleging misleading statements related to a secondary stock offering and an acquisition by AbbVie Inc. [1][5] Group 1: Lawsuit Details - The class action lawsuit targets individuals or entities that sold or held Cerevel stock from October 11, 2023, to August 1, 2024, and those entitled to vote on the merger with AbbVie [1] - The lawsuit claims that during the class period, Cerevel's controlling shareholders, Bain Capital and Pfizer, made false statements regarding a secondary stock offering, which allowed Bain to acquire shares at a discounted price before AbbVie's acquisition announcement [5] - Following the secondary offering, AbbVie announced its acquisition of Cerevel for $45 per share, nearly double the offering price, resulting in Bain Capital receiving over $120 million in windfall profits [5] Group 2: Next Steps for Investors - Investors wishing to join the class action can do so without any out-of-pocket fees through a contingency fee arrangement [2] - Interested parties can visit the provided link or contact Rosen Law Firm for more information on participating in the class action [3][6] - A lead plaintiff must file a motion with the court by June 3, 2025, to represent other class members [1][3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4] - The firm has consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions for investors [4]

Group 1 - The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of UnitedHealth Group due to allegations of materially misleading business information [1] - UnitedHealth's stock fell 22.3% on April 17, 2025, after the company reported earnings that fell short of Wall Street's expectations and downgraded its projected results for 2025, citing issues in its Medicare business [3] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses, allowing affected shareholders to join without any out-of-pocket fees through a contingency fee arrangement [2] Group 2 - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3] - The founding partner of the firm was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation in the field [3]

Group 1 - Monteverde & Associates PC is investigating iCAD, Inc. in relation to its proposed merger with RadNet, Inc., where iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share of iCAD common stock held at the closing of the merger [1] - Monteverde & Associates PC has a successful track record in recovering millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] - The firm operates from the Empire State Building in New York City and is a national class action securities firm with experience in trial and appellate courts, including the U.S. Supreme Court [2][3] Group 2 - The firm encourages shareholders with concerns regarding iCAD, Inc. to visit their website or contact them for additional information free of charge [3] - Monteverde & Associates PC emphasizes that no company, director, or officer is above the law, reinforcing their commitment to shareholder rights [3] - The firm provides a platform for potential clients to inquire about their litigation history and success in recovering funds for shareholders [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of HealthEquity, Inc. due to allegations of materially misleading business information issued by the company [1] Group 1: Investigation and Legal Action - Rosen Law Firm is preparing a class action to seek recovery of investor losses for those who purchased HealthEquity securities [2] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] Group 2: Company Performance and Market Reaction - HealthEquity's shares fell 17% on March 19, 2025, after an article reported that the company missed profit estimates and provided weak guidance due to increased criminal activity targeting the firm [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4] - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered over $438 million for investors in 2019 alone [4]

Core Viewpoint - Zynex, Inc. is facing allegations of issuing materially false and misleading statements, leading to potential legal consequences and financial repercussions for the company [1]. Allegations Summary - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, inflating its revenue [1]. - The company's practice of filing false claims has drawn scrutiny from insurers, including the U.S. military health insurance program, Tricare [1]. - As a result of these practices, Zynex is likely to face adverse consequences, including removal from insurer networks and penalties from the federal government [1]. - The positive statements made by the defendants regarding the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Class Action Details - The class period for the allegations is from March 13, 2023, to March 11, 2025 [1]. - Shareholders are encouraged to register for the class action by May 19, 2025, to participate in potential recovery [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case [2]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].